# SLN (Silence Therapeutics plc) - SEC EDGAR Financial Statements

> Silence Therapeutics plc reported $456K in revenue and a net loss of $51.42M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a 95.0% gross margin and a -12343.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/SLN
- Markdown: https://convexityos.com/fundamentals/SLN.md
- SEC CIK: 0001479615
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:31 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001479615&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $456K | -100.0% YoY |
| Operating Income | TTM | -$56.29M | -12343.6% margin |
| Net Income | TTM | -$51.42M | -11276.5% net margin |
| Diluted EPS | TTM | -$0.31 | Split-adjusted |
| Free Cash Flow | TTM | -$44.15M | -9681.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $247.7M | Total debt: $87K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $559K | $43.26M | $31.64M | $21.66M |
| Cost of Revenue | $215K | $11.81M | $12.87M | $13.46M |
| **Gross Profit** | $344K | $31.45M | $18.78M | $8.19M |
| Research & Development | $67.75M | $67.88M | $56.94M | $43.55M |
| **Operating Income** | -$91.08M | -$63.32M | -$64.38M | -$61.04M |
| **EBITDA** | -$90.52M | -$62.73M | -$63.76M | -$60.44M |
| Income Before Tax | -$88.60M | -$44.46M | -$53.27M | -$49.65M |
| Income Tax Expense | $11K | $845K | $956K | $688K |
| **Net Income** | -$88.61M | -$45.31M | -$54.23M | -$50.33M |
| Basic EPS | -$0.63 | -$0.33 | -$0.49 | -$0.52 |
| **Diluted EPS** | -$0.63 | -$0.33 | -$0.49 | -$0.52 |
| Basic Shares Outstanding | 141.7M | 138.8M | 111.3M | 96.6M |
| Diluted Shares Outstanding | 141.7M | 138.8M | 111.3M | 96.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $422K | $34K | $159K | $224K | $142K | $25.30M |
| Cost of Revenue | $0 | $0 | $11K | $12K | $64K | $85K | $54K | $2.04M |
| **Gross Profit** | $0 | $0 | $411K | $22K | $95K | $139K | $88K | $23.27M |
| Research & Development | $9.30M | $9.15M | $9.12M | $8.75M | $20.54M | $17.65M | $20.81M | $22.08M |
| **Operating Income** | -$14.22M | -$13.87M | -$15.74M | -$12.46M | -$26.24M | -$23.96M | -$28.41M | -$4.35M |
| **EBITDA** | -$14.12M | -$13.76M | -$15.63M | -$12.35M | -$26.09M | -$23.82M | -$28.27M | -$4.21M |
| Income Before Tax | -$12.43M | -$12.27M | -$14.96M | -$11.77M | -$20.96M | -$27.34M | -$28.53M | $12.63M |
| Income Tax Expense | $0 | $1.0K | $0 | $0 | $1.0K | $10K | $0 | $324K |
| **Net Income** | -$12.43M | -$12.27M | -$14.96M | -$11.77M | -$20.96M | -$27.35M | -$28.53M | $12.30M |
| Basic EPS | -$0.08 | -$0.09 | -$0.11 | -- | -$0.15 | -$0.19 | -$0.20 | -- |
| **Diluted EPS** | -$0.08 | -$0.09 | -$0.11 | -- | -$0.15 | -$0.19 | -$0.20 | -- |
| Basic Shares Outstanding | 165.6M | 141.7M | 141.7M | -- | 141.7M | 141.7M | 141.7M | -- |
| Diluted Shares Outstanding | 165.6M | 141.7M | 141.7M | -- | 141.7M | 141.7M | 141.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.28M | $121.3M | $68.79M |
| Short-Term Investments | $73.84M | $26.00M | -- |
| **Cash & Short-Term Investments** | $85.10M | $147.3M | $68.79M |
| Accounts Receivable, Net | $0 | $972K | $290K |
| Other Current Assets | $11.54M | $14.66M | $11.63M |
| **Total Current Assets** | $118.7M | $187.4M | $103.2M |
| Property, Plant & Equipment, Net | $1.58M | $1.82M | $1.94M |
| Goodwill | $10.62M | $9.39M | $9.98M |
| Intangible Assets | $288K | $312K | -- |
| Other Non-Current Assets | $127K | $3.59M | $3.65M |
| **Total Non-Current Assets** | $12.78M | $15.27M | $16.30M |
| **Total Assets** | $131.4M | $202.6M | $119.4M |
| Accounts Payable | $4.41M | $3.70M | $3.35M |
| Deferred Revenue (Current) | $168K | $306K | $6.57M |
| **Total Current Liabilities** | $13.61M | $16.82M | $22.34M |
| Deferred Revenue (Non-Current) | $55.45M | $51.79M | $75.00M |
| **Total Non-Current Liabilities** | $55.52M | $51.79M | $75.12M |
| **Total Liabilities** | $69.14M | $68.61M | $97.45M |
| **Total Debt (incl. Leases)** | $160K | $117K | $346K |
| Common Stock | $10.29M | $10.29M | $8.85M |
| Retained Earnings | -$562.6M | -$474.0M | -$431.9M |
| Accumulated Other Comp. Income | -$2.98M | -$11.78M | -$10.72M |
| **Total Stockholders' Equity** | $62.30M | $134.0M | $21.99M |
| Total Equity | $62.30M | $134.0M | $21.99M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $247.7M | $72.05M | $5.66M | $11.28M | $82.03M | $41.74M | $64.89M | $121.3M |
| Short-Term Investments | $0 | $0 | $64.42M | $73.84M | $20.16M | $72.42M | $71.65M | $26.00M |
| **Cash & Short-Term Investments** | $247.7M | $72.10M | $70.10M | $85.10M | $102.2M | $114.2M | $136.5M | $147.3M |
| Accounts Receivable, Net | -- | -- | $0 | $0 | $28K | $85K | $41K | $972K |
| Other Current Assets | $11.94M | $12.94M | $10.56M | $11.54M | $9.26M | $14.36M | $16.42M | $14.66M |
| **Total Current Assets** | $269.6M | $94.28M | $102.9M | $118.7M | $133.6M | $148.6M | $169.8M | $187.4M |
| Property, Plant & Equipment, Net | $1.22M | $1.32M | $1.40M | $1.58M | $1.66M | $1.77M | $1.69M | $1.82M |
| Goodwill | $10.25M | $10.32M | $10.36M | $10.62M | $10.62M | $10.62M | $10.62M | $9.39M |
| Intangible Assets | -- | -- | -- | $288K | -- | -- | -- | $312K |
| Other Non-Current Assets | $127K | $127K | $127K | $127K | $399K | $3.91M | $3.61M | $3.59M |
| **Total Non-Current Assets** | $11.92M | $12.13M | $12.27M | $12.78M | $13.16M | $16.68M | $15.51M | $15.27M |
| **Total Assets** | $281.5M | $106.4M | $115.1M | $131.4M | $146.8M | $165.2M | $185.3M | $202.6M |
| Accounts Payable | -- | -- | -- | $4.41M | -- | -- | -- | $3.70M |
| Deferred Revenue (Current) | $0 | $0 | $0 | $168K | $301K | $457K | $392K | $306K |
| **Total Current Liabilities** | $11.26M | $12.71M | $10.46M | $13.61M | $17.38M | $14.77M | $19.26M | $16.82M |
| Deferred Revenue (Non-Current) | $55.22M | $55.22M | $55.22M | $55.45M | $55.25M | $56.31M | $53.29M | $51.79M |
| **Total Non-Current Liabilities** | $55.22M | $55.23M | $55.26M | $55.52M | $55.35M | $56.31M | $53.29M | $51.79M |
| **Total Liabilities** | $66.48M | $67.94M | $65.72M | $69.14M | $72.73M | $71.08M | $72.56M | $68.61M |
| **Total Debt (incl. Leases)** | $87K | $112K | $136K | $160K | $182K | -- | $60K | $117K |
| Common Stock | $13.33M | $10.29M | $10.29M | $10.29M | $10.29M | $10.29M | $10.29M | $10.29M |
| Retained Earnings | -$601.9M | -$589.6M | -$577.5M | -$562.6M | -$550.8M | -$529.8M | -$502.5M | -$474.0M |
| Accumulated Other Comp. Income | -$3.48M | -$3.34M | -$3.37M | -$2.98M | -$3.07M | -$1.40M | -$8.08M | -$11.78M |
| **Total Stockholders' Equity** | $215.0M | $38.47M | $49.40M | $62.30M | $74.06M | $94.16M | $112.7M | $134.0M |
| Total Equity | $215.0M | $38.47M | $49.40M | $62.30M | $74.06M | $94.16M | $112.7M | $134.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$88.61M | -$45.31M | -$54.23M | -$50.33M |
| Depreciation & Amortization | $555K | $593K | $621K | $596K |
| Stock-Based Compensation | $8.07M | $16.31M | $16.27M | $12.69M |
| Change in Receivables | $1.02M | -$904K | $392K | -$723K |
| **Operating Cash Flow** | -$62.27M | -$67.64M | -$49.46M | -$57.04M |
| Capital Expenditure | -$55K | -$211K | -$56K | -$173K |
| **Free Cash Flow** | -$62.33M | -$67.85M | -$49.52M | -$57.22M |
| **Investing Cash Flow** | -$47.99M | -$21.97M | $19.29M | -$20.50M |
| Common Stock Issued | $15K | $142.1M | $31.94M | $52.58M |
| **Financing Cash Flow** | $15K | $142.1M | $31.94M | $52.58M |
| **Net Change in Cash** | -$110.2M | $52.48M | $1.77M | -$24.96M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.43M | -$12.27M | -$14.96M | -$11.77M | -$20.96M | -$27.35M | -$28.53M | $12.30M |
| Depreciation & Amortization | $106K | $108K | $106K | $113K | $156K | $148K | $138K | $140K |
| Stock-Based Compensation | $777K | $1.31M | $2.45M | -$86K | $2.54M | $2.08M | $3.54M | $3.98M |
| Change in Receivables | $0 | $0 | $0 | $30K | $62K | -$8.0K | $940K | -$611K |
| **Operating Cash Flow** | -$12.78M | $1.52M | -$15.60M | -$17.29M | -$10.89M | -$21.78M | -$12.31M | -$27.48M |
| Capital Expenditure | $0 | $0 | $0 | $0 | -$3.0K | -$48K | -$4.0K | -$62K |
| **Free Cash Flow** | -$12.78M | $1.52M | -$15.60M | -$17.29M | -$10.89M | -$21.83M | -$12.31M | -$27.54M |
| **Investing Cash Flow** | $0 | $64.94M | $10.00M | -$53.34M | $51.29M | -$1.56M | -$44.38M | $66.12M |
| Common Stock Issued | $188.3M | $2.0K | $0 | $0 | $0 | $1.0K | $14K | -$98K |
| **Financing Cash Flow** | $188.3M | $2.0K | $0 | $0 | $0 | $1.0K | $14K | -$98K |
| **Net Change in Cash** | $175.6M | $66.46M | -$5.60M | -$70.62M | $40.40M | -$23.34M | -$56.68M | $38.55M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 61.5% | 72.7% | 59.3% | 37.8% |
| **Operating Margin** | -16292.8% | -146.4% | -203.5% | -281.9% |
| **Net Profit Margin** | -15851.9% | -104.7% | -171.4% | -232.4% |
| Return on Equity (ROE) | -142.2% | -33.8% | -246.6% | -- |
| Return on Assets (ROA) | -67.4% | -22.4% | -45.4% | -- |
| Current Ratio | 8.72x | 11.14x | 4.62x | -- |
| Quick Ratio | 6.25x | 8.81x | 3.09x | -- |
| Debt to Equity | 0.00x | 0.00x | 0.02x | -- |
| **Revenue Growth (YoY)** | -98.7% | +36.7% | +46.1% | -- |
| Gross Profit Growth (YoY) | -98.9% | +67.5% | +129.2% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 95.0% | 85.9% | 79.5% | 61.5% | 91.3% | 78.6% | 67.3% | 72.7% |
| **Operating Margin** | -12343.6% | -11106.8% | -9345.1% | -16292.8% | -321.2% | -319.2% | -311.0% | -146.4% |
| **Net Profit Margin** | -11276.5% | -9748.5% | -8943.9% | -15851.9% | -249.9% | -291.2% | -258.2% | -104.7% |
| Return on Equity (ROE) | -23.9% | -155.8% | -151.9% | -142.2% | -87.1% | -84.0% | -63.4% | -33.8% |
| Return on Assets (ROA) | -18.3% | -56.3% | -65.2% | -67.4% | -44.0% | -47.9% | -38.6% | -22.4% |
| Current Ratio | 23.94x | 7.42x | 9.83x | 8.72x | 7.69x | 10.06x | 8.81x | 11.14x |
| Quick Ratio | 22.00x | 5.67x | 6.70x | 6.25x | 5.88x | 7.74x | 7.09x | 8.81x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -- | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -100.0% | -100.0% | +197.2% | -99.9% | -89.4% | -70.4% | -99.1% | -- |
| Gross Profit Growth (YoY) | -100.0% | -100.0% | +367.0% | -99.9% | -- | -- | -99.3% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -195.7% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
